Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-05 5:42 pm Sale | 2025-11-19 | 13G | Agios Pharmaceuticals, Inc. AGIO | Bellevue Group AG | 0 0.000% | -3,515,150 (Position Closed) | Filing History |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Paradigm BioCapital Advisors LP | 2,873,555 4.900% | -154,422 (-5.10%) | Filing History |
| 2025-08-28 4:31 pm Purchase | 2025-08-21 | 13G | Agios Pharmaceuticals, Inc. AGIO | Paradigm BioCapital Advisors LP | 3,027,977 5.200% | 3,027,977 (New Position) | Filing History |
| 2025-07-17 7:44 pm Sale | 2025-06-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 4,513,170 7.800% | -449,067 (-9.05%) | Filing History |
| 2025-07-07 7:32 pm Purchase | 2025-06-01 | 13G | Agios Pharmaceuticals, Inc. AGIO | Bellevue Group AG | 3,515,150 6.100% | 3,515,150 (New Position) | Filing History |
| 2025-06-13 2:50 pm Sale | 2025-06-01 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 0 0.000% | -3,515,150 (Position Closed) | Filing History |
| 2025-02-14 2:35 pm Sale | 2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 3,515,150 6.200% | -484,850 (-12.12%) | Filing History |
| 2025-02-04 12:02 pm Purchase | 2024-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 5,674,466 9.900% | 13,600 (+0.24%) | Filing History |
| 2024-11-14 3:44 pm Sale | 2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Armistice Capital, LLC | 2,207,070 3.880% | -1,316,930 (-37.37%) | Filing History |
| 2024-11-08 2:40 pm Purchase | 2024-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 5,660,866 9.900% | 1,493,264 (+35.83%) | Filing History |
| 2024-02-14 2:21 pm Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Armistice Capital, LLC | 3,524,000 6.310% | 774,000 (+28.15%) | Filing History |
| 2024-02-14 2:06 pm Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Rock Springs Capital Management LP | 2,152,173 3.850% | -844,419 (-28.18%) | Filing History |
| 2024-02-13 06:07 am Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,000,000 7.200% | -30,792 (-0.76%) | Filing History |
| 2024-02-12 11:21 am Purchase | 2024-01-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | The Vanguard Group | 5,599,917 10.020% | 72,479 (+1.31%) | Filing History |
| 2024-02-12 10:50 am Purchase | 2023-12-29 | 13G | Agios Pharmaceuticals, Inc. AGIO | The Vanguard Group | 5,527,438 9.890% | 192,362 (+3.61%) | Filing History |
| 2024-02-08 11:39 am Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 4,167,602 7.500% | 206,000 (+5.20%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 4,962,237 8.900% | 193,363 (+4.05%) | Filing History |
| 2024-01-22 12:37 pm Sale | 2023-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 2,625,685 4.700% | -553,383 (-17.41%) | Filing History |
| 2023-11-09 5:18 pm Purchase | 2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Farallon Capital Partners, L.P. | 3,961,602 7.100% | 3,961,602 (New Position) | Filing History |
| 2023-11-09 1:26 pm Sale | 2023-10-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | Wellington Management Group LLP | 2,200,757 3.950% | -3,522,374 (-61.55%) | Filing History |